Saffron therapy for the ongoing treatment of age-related macular degeneration
Objective To assess the long-term efficacy and safety of oral saffron, a natural antioxidant, in treating mild/moderate age-related macular degeneration (AMD).Methods and analysis Open-label, extension trial of 93 adults (>50 years) with mild/moderate AMD and vision >20/70 Snellen equi...
Saved in:
Main Authors: | Peter J McCluskey, Thomas Hong, Andrew A Chang, John Grigg, Geoffrey K Broadhead, Timothy E Schlub, Eugenia Chu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Open Ophthalmology |
Online Access: | https://bmjophth.bmj.com/content/9/1/e001399.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem cells for age-related macular degeneration
by: L.K. Moshetova, et al.
Published: (2019-09-01) -
Targeted Therapy on Age-Related Macular Degeneration
by: Vankodoth Sireesha, et al.
Published: (2024-12-01) -
Mechanism of Inflammation in Age-Related Macular Degeneration
by: Francesco Parmeggiani, et al.
Published: (2012-01-01) -
Relationship of Retinal Vessel Caliber with Age-Related Macular Degeneration
by: Sara Toulouie, et al.
Published: (2022-01-01) -
Role of inflammatory aging in the development of age-related macular degeneration
by: A.S. Khalatyan, et al.
Published: (2024-09-01)